EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson’s disease

Yu'an Li, Chunlei Yu, Xiaobing Jiang, Jia Fu, Ning Sun, Daquan Zhang

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155349 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Yu'an Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Jilin Province FAW General Hospital, Changchun 130000, China. Hauptthemen laut MEDLINE: Parkinson Disease, RNA, Untranslated. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 148 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to motor and non-motor symptoms. Emerging evidence suggests that inflammation plays a crucial role in the pathogenesis of PD, with the NLRP3 inflammasome implicated as a key mediator. Nfon-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), have recently garnered attention for their regulatory roles in various biological processes, including inflammation. This review aims to provide a mechanistic insight into how ncRNAs function as regulators of inflammatory pathways in PD, with a specific focus on the NLRP3 inflammasome. We discuss the dysregulation of miRNAs and lncRNAs in PD pathogenesis and their impact on neuroinflammation through modulation of NLRP3 activation, cytokine production, and microglial activation. Additionally, we explore the crosstalk between ncRNAs, alpha-synuclein pathology, and mitochondrial dysfunction, further elucidating the intricate network underlying PD-associated inflammation. Understanding the mechanistic roles of ncRNAs in regulating inflammatory pathways may offer novel therapeutic targets for the treatment of PD and provide insights into the broader implications of ncRNA-mediated regulation in neuroinflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseRNA, UntranslatedHumansInflammasomesAnimalsRNA, Long NoncodingInflammationNLR Family, Pyrin Domain-Containing 3 ProteinNeuroinflammatory DiseasesMicroRNAs

Stichwörter der Autor:innen

InflammationNLRP3Parkinson's diseasecircRNAslncRNAsmiRNAsncRNAs

Substanzen

RNA, UntranslatedInflammasomesRNA, Long NoncodingNLR Family, Pyrin Domain-Containing 3 ProteinMicroRNAs

Autor:innen und Institutionen

  • Department of Neurosurgery, Jilin Province FAW General Hospital, Changchun 130000, China.
  • Department of Neurosurgery, Jilin Province FAW General Hospital, Changchun 130000, China. Electronic address: 18946785281@163.com.

Zitieren

APA

Li, Y., Yu, C., Jiang, X., Fu, J., Sun, N., & Zhang, D. (2024). The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson’s disease. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155349

Vancouver

Li Y, Yu C, Jiang X, Fu J, Sun N, Zhang D. The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson’s disease. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155349

BibTeX
@article{Li2024,
  author = {Li, Yu'an and Yu, Chunlei and Jiang, Xiaobing and Fu, Jia and Sun, Ning and Zhang, Daquan},
  title = {The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson’s disease},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155349}
}
Kostenlos starten →